Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EU And India Bury Hatchet Over Drug Seizures But Companies Fear ACTA May Bring More Pains

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - Leading pharmaceutical lobby groups - the Indian Drug Manufacturers Association and the Indian Pharmaceutical Alliance - cautiously welcomed the resolution of a trade dispute with the European Union that for more than two years saw random seizure of several generic drug consignments from Indian companies at select European ports

You may also be interested in...

Headway Seen In EU-India FTA Talks, Commerce Ministry Joint Secretary Says

Disputes over EU blockades of Indian drug shipments are still on the negotiation table, says Commerce Ministry. India hopes to initiate talks with China as well.

India Says Counterfeit Drugs Should Be Handled By WTO - Not WHO

MUMBAI - Years of strong opposition from the Indian government, bolstered by recent support in that effort by some Latin American, African and South-East Asian countries, has exerted pressure on the World Health Assembly to establish a working group to handle the controversy surrounding the definition of "substandard" and "counterfeit" drugs

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts